Clinical Trial Update: A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the BGM1812 injection in healthy and non-diabetic overweight or obese Chinese participants; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM1812

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Overweight or Obesity | Phase 1 | Status: RECRUITING